This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hondeghem, L. Articles by Katzung, B. G. Search for Related Content PubMed PubMed Citation Articles by Hondeghem, L. Articles by Katzung, B. G.

Circulation, Vol 61, 1217-1224, Copyright © 1980 by American Heart Association

ARTICLES

Test of a model of antiarrhythmic drug action. Effects of quinidine and lidocaine on myocardial conduction

L Hondeghem and BG Katzung

The effects of quinidine and lidocaine on the maximum upstroke velocity (Vmax) of the ventricular myocardial action potential were compared with the effects predicted by a model over a wide range of driving rates, rhythm disturbances and holding potentials. These rate-, rhythm- and voltage-dependent effects were accurately predicted by the proposed model. The model was also able to predict several previously undocumented properties of the drugs: 1) If lidocaine decreases Vmax of a pulse train, the steady state is reached within a few action potentials. 2) The poststimulation recovery of Vmax in the presence of lidocaine or quinidine can occur in a multiexponential fashion, if the membrane potential is kept at the potential where both the fast (operating mainly at more negative membrane potentials) and the slow (operating at more positive potentials) recovery processes are operative. 3) Hyperpolarization markedly attenuates the rate-dependent drug effects. 4) Combinations of lidocaine and quinidine have a superadditive effect on the Vmax of early extrasystoles.

This article has been cited by other articles:

				T. Campbell Kinetics of onset of rate-dependent effects of Class I antiarrhythmic drugs are important in determining their effects on refractoriness in guinea-pig ventricle, and provide a theoretical basis for their subclassification Cardiovasc Res, January 1, 2000; 45(1): 55 - 56. [Full Text] [PDF]

				R. Valdes Jr., S. A. Jortani, and M. Gheorghiade Standards of laboratory practice: cardiac drug monitoring Clin. Chem., May 1, 1998; 44(5): 1096 - 1109. [Abstract] [Full Text] [PDF]

				H. Fei, D. Yazmajian, M. S. Hanna, and L. H. Frame Termination of Reentry by Lidocaine in the Tricuspid Ring In Vitro: Role of Cycle-Length Oscillation, Fast Use-Dependent Kinetics, and Fixed Block Circ. Res., February 1, 1997; 80(2): 242 - 252. [Abstract] [Full Text]